Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics Statistics

Total Valuation

ORKA has a market cap or net worth of $576.74 million. The enterprise value is $227.61 million.

Market Cap	576.74M
Enterprise Value	227.61M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ORKA has 37.45 million shares outstanding.

Current Share Class	37.45M
Shares Outstanding	37.45M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.00%
Owned by Insiders (%)	3.09%
Owned by Institutions (%)	65.74%
Float	22.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.69
P/TBV Ratio	1.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 27.42, with a Debt / Equity ratio of 0.01.

Current Ratio	27.42
Quick Ratio	27.12
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-188.91

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-34.87%
Revenue Per Employee	n/a
Profits Per Employee	-$2.77M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.84% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-47.84%
50-Day Moving Average	14.58
200-Day Moving Average	13.46
Relative Strength Index (RSI)	52.74
Average Volume (20 Days)	135,954

Short Selling Information

The latest short interest is 3.20 million, so 8.54% of the outstanding shares have been sold short.

Short Interest	3.20M
Short Previous Month	4.30M
Short % of Shares Out	8.54%
Short % of Float	14.27%
Short Ratio (days to cover)	22.61

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-120.42M
Pretax Income	n/a
Net Income	-77.43M
EBITDA	n/a
EBIT	-120.42M
Earnings Per Share (EPS)	-$2.14

Balance Sheet

The company has $328.41 million in cash and $2.33 million in debt, giving a net cash position of $349.13 million or $9.32 per share.

Cash & Cash Equivalents	328.41M
Total Debt	2.33M
Net Cash	349.13M
Net Cash Per Share	$9.32
Equity (Book Value)	343.64M
Book Value Per Share	9.10
Working Capital	319.90M

Cash Flow

In the last 12 months, operating cash flow was -$95.91 million and capital expenditures -$253,182, giving a free cash flow of -$96.16 million.

Operating Cash Flow	-95.91M
Capital Expenditures	-253,182
Free Cash Flow	-96.16M
FCF Per Share	-$2.57

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORKA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-13.43%
FCF Yield	-16.67%

Analyst Forecast

The average price target for ORKA is $40.43, which is 161.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$40.43
Price Target Difference	161.68%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 3, 2024. It was a reverse split with a ratio of 1:12.

Last Split Date	Sep 3, 2024
Split Type	Reverse
Split Ratio	1:12

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a